These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 22437818)

  • 1. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
    Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus report on the future of animal-free systemic toxicity testing.
    Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T
    ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New animal-free concepts and test methods for developmental toxicity and peripheral neurotoxicity.
    Leist M
    Altern Lab Anim; 2017 Nov; 45(5):253-260. PubMed ID: 29112453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
    Trosko JE
    Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECVAM's research and validation activities in the fields of topical toxicity and human studies.
    Zuang V
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():119-23. PubMed ID: 12513662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.
    Shinde V; Klima S; Sureshkumar PS; Meganathan K; Jagtap S; Rempel E; Rahnenführer J; Hengstler JG; Waldmann T; Hescheler J; Leist M; Sachinidis A
    J Vis Exp; 2015 Jun; (100):e52333. PubMed ID: 26132533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
    Basketter DA; Clewell H; Kimber I; Rossi A; Blaauboer B; Burrier R; Daneshian M; Eskes C; Goldberg A; Hasiwa N; Hoffmann S; Jaworska J; Knudsen TB; Landsiedel R; Leist M; Locke P; Maxwell G; McKim J; McVey EA; Ouédraogo G; Patlewicz G; Pelkonen O; Roggen E; Rovida C; Ruhdel I; Schwarz M; Schepky A; Schoeters G; Skinner N; Trentz K; Turner M; Vanparys P; Yager J; Zurlo J; Hartung T
    ALTEX; 2012; 29(1):3-91. PubMed ID: 22307314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we need a "Chair of alternative methods", and where?
    Wendel A
    ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration.
    Pallocca G; Grinberg M; Henry M; Frickey T; Hengstler JG; Waldmann T; Sachinidis A; Rahnenführer J; Leist M
    Arch Toxicol; 2016 Jan; 90(1):159-80. PubMed ID: 26705709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.